Manual of Hypertension of the European Society of Hypertension, Second Edition

 Content: Front Cover; Contents; Preface; Contributors; Chapter 1: EPIDEMIOLOGY OF HYPERTENSION; Chapter 2: THE TOTAL CARDIOVASCULAR RISK; Chapter 3: CLASSICAL AND NEW RISK FACTORS; Chapter 4: PULSE PRESSURE AS A CARDIOVASCULAR RISK FACTOR; Chapter 5: CLINICAL SIGNIFICANCE OF HIGH HEART RATE IN HYPERTENSION; Chapter 6: OBESITY AND OBSTRUCTIVE SLEEP APNEA; Chapter 7: DIABETES MELLITUS; Chapter 8: STRESS-RELATED, PSYCHOSOCIAL, AND OTHER RISK FACTORS IN THE HYPERTENSIVE PATIENT; Chapter 9: BLOOD PRESSURE VARIABILITY: METHODOLOGICAL ASPECTS, PHYSIOLOGY, AND CLINICAL IMPLICATIONS. Chapter 10: ANTIHYPERTENSIVE TREATMENT STRATEGIESChapter 11: HEMODYNAMICS OF HYPERTENSION; Chapter 12: GENETIC BASIS OF BLOOD PRESSURE AND HYPERTENSION; Chapter 13: STRUCTURAL CARDIOVASCULAR CHANGES IN HYPERTENSION; Chapter 14: IMPAIRED AUTONOMIC CARDIOVASCULAR CONTROL IN HYPERTENSION; Chapter 15: THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM; Chapter 16: ETIOLOGICAL AND PATHOPHYSIOLOGICAL ASPECTS OF HYPERTENSION: OTHER HUMORAL-ENDOCRINE FACTORS; Chapter 17: CARDIAC DAMAGE AND PROGRESSION TO HEART FAILURE; Chapter 18: BRAIN DAMAGE. Chapter 19: LARGE ARTERY DAMAGE: MEASUREMENT AND CLINICAL IMPORTANCEChapter 20: SMALL ARTERY STRUCTURE AND FUNCTION IN HYPERTENSION; Chapter 21: ENDOTHELIAL DAMAGE: MEASUREMENT AND CLINICAL IMPORTANCE; Chapter 22: RENAL DAMAGE AND HYPERTENSION: MECHANISMS OF RENAL END-ORGAN DAMAGE; Chapter 23: RETINAL CHANGES IN HYPERTENSION; Chapter 24: BP MEASUREMENTS AND OTHER DIAGNOSTIC PROCEDURES; Chapter 25: BLOOD PRESSURE RESPONSE TO ACUTE PHYSICAL AND MENTAL STRESS; Chapter 26: CENTRAL BLOOD PRESSURE; Chapter 27: THE DIAGNOSTIC APPROACH IN UNCOMPLICATED AND COMPLICATED HYPERTENSION. Chapter 28: BLOOD PRESSURE TARGETS OF ANTIHYPERTENSIVE TREATMENTChapter 29: INTERVENTIONAL TRIALS IN HYPERTENSION: WHAT HAVE WE LEARNED AND WHAT REMAINS TO BE LEARNED?; Chapter 30: THE NEPHROPROTECTIVE EFFECT OF ANTIHYPERTENSIVE TREATMENT; Chapter 31: NONPHARMACOLOGICAL INTERVENTIONS; Chapter 32: MEDICAL TREATMENT OF HYPERTENSION: MONOTHERAPY AND COMBINATION THERAPY; Chapter 33: EMERGING ANTIHYPERTENSIVE DRUGS; Chapter 34: THE POLYPILL; Chapter 35: INVASIVE PROCEDURES; Chapter 36: CLINICAL MANAGEMENT OF PATIENTS PRESENTING WITH HYPERTENSION AND PERIPHERAL ARTERY DISEASE. Chapter 37: RESISTANT AND MALIGNANT HYPERTENSIONChapter 38: HYPERTENSIVE EMERGENCIES AND URGENCIES; Chapter 39: SECONDARY HYPERTENSION: DIAGNOSIS AND TREATMENT; Chapter 40: HYPERTENSION IN DIABETES MELLITUS; Chapter 41: HYPERTENSION IN CHILDREN AND ADOLESCENTS; Chapter 42: HYPERTENSION IN PREGNANCY; Chapter 43: POSTTRANSPLANT HYPERTENSION; Chapter 44: HYPERTENSION IN PATIENTS WITH RENAL PARENCHYMAL DISEASE, CHRONIC RENAL FAILURE, AND CHRONIC DIALYSIS; Chapter 45: THE METABOLIC SYNDROME IN HYPERTENSION; Chapter 46: WHITE-COAT AND MASKED HYPERTENSION; Chapter 47: SECONDARY PREVENTION OF STROKE.
 Abstract:             Despite recent advances in healthcare, hypertension is a leading cause of death and remains a disease burden worldwide. Now in its second edition, the Manual of Hypertension of the European Society of Hypertension reflects emerging concepts that have the potential to impact diagnostic and therapeutic approaches to this condition. Updating all material, this new edition also delves into a number of areas that have received heightened interest in recent years or have become a matter of debate due to the controversial interpretation of the available data. Topics include: